Cargando…
Central nervous system uptake of intranasal glutathione in Parkinson’s disease
Glutathione (GSH) is depleted early in the course of Parkinson’s disease (PD), and deficiency has been shown to perpetuate oxidative stress, mitochondrial dysfunction, impaired autophagy, and cell death. GSH repletion has been proposed as a therapeutic intervention. The objective of this study was t...
Autores principales: | Mischley, Laurie K, Conley, Kevin E, Shankland, Eric G, Kavanagh, Terrance J, Rosenfeld, Michael E, Duda, John E, White, Collin C, Wilbur, Timothy K, De La Torre, Prysilla U, Padowski, Jeannie M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516583/ https://www.ncbi.nlm.nih.gov/pubmed/28725693 http://dx.doi.org/10.1038/npjparkd.2016.2 |
Ejemplares similares
-
Phase IIb Study of Intranasal Glutathione in Parkinson’s Disease
por: Mischley, Laurie K., et al.
Publicado: (2017) -
Glutathione as a Biomarker in Parkinson's Disease: Associations with Aging and Disease Severity
por: Mischley, Laurie K., et al.
Publicado: (2016) -
ATP and NAD(+) Deficiency in Parkinson’s Disease
por: Mischley, Laurie K., et al.
Publicado: (2023) -
Synergy of pandemics-social isolation is associated with worsened Parkinson severity and quality of life
por: Subramanian, Indu, et al.
Publicado: (2020) -
Role of Diet and Nutritional Supplements in Parkinson's Disease Progression
por: Mischley, Laurie K., et al.
Publicado: (2017)